Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
A large NIH-funded trial found that adding one dose of azithromycin to standard prophylaxis roughly halved infections after unplanned cesarean. Here is what it showed and how guidance changed.
Azithromycin in the first weeks of life is linked to a higher risk of pyloric stenosis, though less clearly than erythromycin. Here is what the studies show and what parents should watch for.
Single-dose azithromycin once cured most Mycoplasma genitalium infections; now resistance is common. Here is why it happened and how resistance-guided therapy restores high cure rates.
A short azithromycin course works because the drug builds up inside cells and tissues and leaves slowly. Here is what the research shows, and what it means for patients.
A 2012 Vanderbilt study linked azithromycin to a small rise in cardiovascular death, prompting an FDA warning. Here is what it found, who is at risk, and what later research added.
A single oral dose of azithromycin, paired with surgery, hygiene, and sanitation, has become the backbone of the global effort to end trachoma blindness.
A single oral dose of azithromycin is replacing painful penicillin shots in the global campaign against yaws. Here is what the evidence actually shows.
Azithromycin was long the go-to single-dose chlamydia treatment, but new evidence has shifted guidance toward doxycycline. Here's what changed, why, and what remains true.
Azithromycin's short course isn't a shortcut — it reflects unique pharmacokinetics that let the drug keep working long after the last pill.